Please assess the completion status of the following clinical trial:

Trial Title: Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed non-small cell lung cancer~* Tumor between 1 cm and 6 cm~* No evidence of nodal involvement or distant metastases~* Deemed to be a candidate for stereotactic body radiation therapy for NSCLC~* Able to lie still during DCE-MRI (up to 60 minutes)~* Adequate renal function to tolerate intravenous gadolinium contrast injection~Exclusion Criteria:~* Prior thoracic radiotherapy or surgery~* Implanted pacemaker or cardiac defibrillator~* Contraindications to undergoing MRI~* Uncontrolled intercurrent illness~* Pregnant or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental Arm (Type: EXPERIMENTAL): Stereotactic Body Radiation Therapy: either 54 Gy in 3 fractions or 50-60 Gy in 5 fraction over a span of 15 days at most.~DCE-MRI was performed at four time points during therapy: at baseline prior to SBRT, 1-2 days after the first treatment fraction, 1-2 weeks after the end of the SBRT course, and 3 months after completing radiotherapy.~4D-CT scan 3 months after completing radiotherapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).